A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids-Reference-Cited by-同舟云学术

A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids

Published:2019-08 Issue: Volume:471 Page:27-33
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Teráz-Orosz Adrienn,Csapó Andrea,Bagoly Zsuzsa,Székely Edina Gabriella,Tóth Eszter,Kovács Bettina,Bereczky Zsuzsanna,Muszbek László^ORCID,Katona Éva

Funder

Development and Innovation Office

European Union

European Regional Development Fund

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma;Bangert;Biochem. J.,1993

2. Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase;Brower;J. Biol. Chem.,1982

3. Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma;Christensen;Biochem. J.,1978

4. The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity;Christiansen;Blood,2007

5. Fast-acting plasmin inhibitor in human plasma;Collen;Blood,1978

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis;Journal of Thrombosis and Haemostasis;2023-04

2. Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis;Frontiers in Cardiovascular Medicine;2022-07-15

3. Fibrin clot properties in coronary artery disease: new determinants and prognostic markers;Polish Archives of Internal Medicine;2021-10-08

4. Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism;Thrombosis Research;2021-07

5. Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients;Biomolecules;2021-02-25